Isoniazid API Manufacturers & Suppliers

Looking for Isoniazid API 54-85-3?

Description:

Here you will find a list of producers, manufacturers and distributors of Isoniazid. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Isoniazid 

Synonyms:

INH , Isoniazid , Isonicotinic acid hydrazide , Isonicotinic hydrazide , Isonicotinohydrazide , Isonicotinoylhydrazide , Isonicotinsaeurehydrazid , Isonicotinylhydrazine , Pyridine-4-carboxylic acid hydrazide  

Cas Number:

54-85-3 

DrugBank number:

DB00951 

Unique Ingredient Identifier:

V83O1VOZ8L

Isoniazid is a type of Anti-tuberclosis agents

Anti-tuberculosis agents are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of tuberculosis (TB), a contagious bacterial infection caused by Mycobacterium tuberculosis. These agents play a crucial role in combating TB by inhibiting the growth and spread of the bacteria.

One of the most commonly used anti-tuberculosis agents is isoniazid, which works by disrupting the synthesis of mycolic acids, essential components of the bacterial cell wall. Another important agent is rifampicin, which inhibits the RNA polymerase enzyme, thus preventing the synthesis of bacterial RNA.

Ethambutol, another widely used agent, disrupts the formation of the bacterial cell wall by inhibiting the arabinosyltransferase enzyme. Pyrazinamide, the fourth main agent, interferes with the metabolism of the bacteria, thereby inhibiting their growth.

Combination therapy involving two or more of these anti-tuberculosis agents is typically employed to achieve the most effective treatment outcomes. This approach helps prevent the development of drug resistance and enhances the bactericidal activity against TB.

The development of anti-tuberculosis agents involves rigorous research, clinical trials, and regulatory approvals. Pharmaceutical companies employ advanced technologies and strict quality control measures to ensure the safety, efficacy, and stability of these APIs.

Overall, the availability of effective anti-tuberculosis agents is crucial in the fight against TB, a global health challenge. Ongoing research and development efforts aim to improve existing agents and develop new ones, with the ultimate goal of eradicating tuberculosis worldwide.

Isoniazid (Anti-tuberclosis agents), classified under Antibacterials

Antibacterials, a category of pharmaceutical active pharmaceutical ingredients (APIs), play a crucial role in combating bacterial infections. These APIs are chemical compounds that target and inhibit the growth or kill bacteria, helping to eliminate harmful bacterial pathogens from the body.

Antibacterials are essential for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and more. They are commonly prescribed by healthcare professionals to combat both mild and severe bacterial infections.

Within the category of antibacterials, there are different classes and subclasses of APIs, each with distinct mechanisms of action and target bacteria. Some commonly used antibacterials include penicillins, cephalosporins, tetracyclines, macrolides, and fluoroquinolones. These APIs work by interfering with various aspects of bacterial cellular processes, such as cell wall synthesis, protein synthesis, DNA replication, or enzyme activity.

The development and production of antibacterial APIs require stringent quality control measures to ensure their safety, efficacy, and purity. Pharmaceutical manufacturers must adhere to Good Manufacturing Practices (GMP) and follow rigorous testing protocols to guarantee the quality and consistency of these APIs.

As bacterial resistance to antibiotics continues to be a significant concern, ongoing research and development efforts aim to discover and develop new antibacterial APIs. The evolution of antibacterials plays a crucial role in combating emerging bacterial strains and ensuring effective treatment options for infectious diseases.

In summary, antibacterials are a vital category of pharmaceutical APIs used to treat bacterial infections. They are designed to inhibit or kill bacteria, and their development requires strict adherence to quality control standards. By continually advancing research in this field, scientists and pharmaceutical companies can contribute to the ongoing battle against bacterial infections.

• Aurora Industry Co., Ltd from China, product country of origin China
• Shandong Octagon Chemicals Limited from China, product country of origin China
• Tenatra Exports Private Limited from India, product country of origin India
• SETV Global from India, product country of origin India
• Amsal Chem from India, product country of origin India
• Tianjin Handewei from China, product country of origin China
• Yuki Gosei Kogyo from Japan, product country of origin Japan
• Shaoxing Hantai Pharma from China, product country of origin China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.